Stelara 130mg-IN (Ustekinumab Vials) 130mg/26ml

Stelara 130mg-IN (ustekinumab) is an injectable prescription medication used for immune-mediated conditions. This 130mg/26ml vial supports treatment plans for moderate to severe plaque psoriasis and psoriatic arthritis. Store between 2-8°C to maintain potency and efficacy. Always follow healthcare provider guidance when using.

Strength

130mg/26ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Cilag AG - Switzerland

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Stelara 130mg-IN is commonly prescribed to reduce inflammation and manage symptoms in immune-mediated diseases such as moderate to severe plaque psoriasis and active psoriatic arthritis. It works by targeting specific pathways in the immune system to help control flare-ups. Patients often ask, 'what is Stelara 130mg-IN used for' and it is important to note this medication is intended for those who have not responded well to other treatments.

Side Effects

Many patients experience reduced skin lesions and joint pain after starting Stelara 130mg-IN therapy. Some notice improved mobility and fewer disease flare-ups over time. Individual responses vary, and consistent use as directed is important for best results. Always discuss any changes in symptoms with a healthcare provider.

Precautions & Warnings

Keep Stelara 130mg-IN refrigerated between 2-8°C and protect from light until ready to use. Do not freeze or shake the vial vigorously. Before injecting, allow the vial to reach room temperature for about 30 minutes. Always check the liquid for particles or discoloration and follow proper disposal guidelines for used vials.

Avoid Interactions

Stelara 130mg-IN may interact with other immunosuppressants or live vaccines. Avoid receiving live vaccines during treatment unless approved by a doctor. Inform your healthcare provider about all medications, including over-the-counter and herbal products. Alcohol use should be discussed with a medical professional before starting therapy.

Frequently Asked Questions

Individual response times vary; some patients notice improvement within a few weeks, while others may take longer. Consistent use as prescribed is important for effectiveness.

The safety of ustekinumab during pregnancy or breastfeeding has not been fully established. Always consult a healthcare provider to discuss potential risks and benefits.

Contact your healthcare provider for guidance if a dose is missed. Do not take a double dose to make up for a missed one without medical advice.

Stelara 130mg-IN is approved for use in children aged 6 years and older for certain conditions. Dosage and safety should be determined by a pediatric specialist.

Alcohol consumption should be discussed with a healthcare provider, as it may affect treatment or increase side effects. Moderation and medical guidance are recommended.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.